Illumination of a Vision 2020—Urinary Based Biomarkers for Bladder Cancer on the Way to Clinical Decisions—Dream or Nightmare?

by Thorsten H. Ecke, Thomas Otto
Published 2020-03-01

Illumination of a Vision—How Arthur Rimbaud Will Give Us Motivation to Find New Input into Bladder Cancer Biomarker Research

by Thorsten H. Ecke, Thomas Otto
Published 2017-11-01

Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?

by Thorsten H. Ecke, Thomas Otto, Florence Le Calvez-Kelm
Published 2020-12-01

Diagnostic and Prognostic Potential of MicroRNA Maturation Regulators Drosha, AGO1 and AGO2 in Urothelial Carcinomas of the Bladder

by Anja Rabien, Nadine Ratert, Anica Högner, Andreas Erbersdobler, Klaus Jung, Thorsten H. Ecke, Ergin Kilic
Published 2018-05-01

UBC Test for detection of carcinoma in situ for bladder cancer

by Thorsten H Ecke, Sarah Weiß, Carsten Stephan, Steffen Hallmann, Dimitri Barski, Thomas Otto, Holger Gerullis
Published 2017-04-01

UBC^® <i>Rapid</i> Test—A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicente...

by Thorsten H. Ecke, Sarah Weiß, Carsten Stephan, Steffen Hallmann, Christian Arndt, Dimitri Barski, Thomas Otto, Holger Gerullis
Published 2018-12-01

Health-related quality of life and rates of toxicity after high-dose-rate brachytherapy in combination with external beam radiation therapy for high-risk prostate cancer

by Hui-Juan Huang-Tiel, Isabella Otto, Klaus Golka, Silvia Selinski, Stephan Koswig, Kathrin Bathe, Steffen Hallmann, Thorsten H. Ecke
Published 2020-05-01

Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non–muscle-invasive Bladder Cancer: A Case Report

by Sarah Weiß, Steffen Hallmann, Stefan Koch, Sebastian Eidt, Robert Stoehr, Elke Veltrup, Jenny Roggisch, Ralph M. Wirtz, Thorsten H. Ecke
Published 2021-05-01

Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Addi...

by Thorsten H. Ecke, Hui-Juan Huang-Tiel, Klaus Golka, Silvia Selinski, Berit Christine Geis, Stephan Koswig, Katrin Bathe, Steffen Hallmann, Holger Gerullis
Published 2016-11-01

SWI/SNF Alterations in Squamous Bladder Cancers

by Fabian Achenbach, Michael Rose, Nadina Ortiz-Brüchle, Lancelot Seillier, Ruth Knüchel, Veronika Weyerer, Arndt Hartmann, Ronja Morsch, Angela Maurer, Thorsten H. Ecke, Stefan Garczyk, Nadine T. Gaisa
Published 2020-11-01

Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of <i>KRT5</i>, <i>KRT20</i>, and <i>ERBB2<...

by Thorsten H. Ecke, Adisch Kiani, Thorsten Schlomm, Frank Friedersdorff, Anja Rabien, Klaus Jung, Ergin Kilic, Peter Boström, Minna Tervahartiala, Pekka Taimen, Jan Gleichenhagen, Georg Johnen, Thomas Brüning, Stefan Koch, Jenny Roggisch, Ralph M. Wirtz
Published 2020-10-01